dacarbazine has been researched along with Glomerulonephritis, Minimal Change in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akioka, T; Hanafusa, T; Hiraoka, N; Hirata, Y; Iwaki, K; Kobayashi, K; Nakayama-Ichiyama, S; Oka, S; Takayama, A; Takubo, T; Tsuji, M; Yokote, T | 1 |
| Akioka, T; Hanafusa, T; Hiraoka, N; Hirata, Y; Kobayashi, K; Miyoshi, T; Nakayama, S; Oka, S; Takubo, T; Tsuji, M; Yokote, T | 1 |
2 other study(ies) available for dacarbazine and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
Multiple-cytokine-producing, mixed-cellularity, classical Hodgkin lymphoma with B symptoms and minimal-change nephrotic syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C-Reactive Protein; Dacarbazine; Doxorubicin; Edema; Fatigue; Fever; Hodgkin Disease; Humans; Immunosuppressive Agents; Interleukin-6; Male; Nephrosis, Lipoid; Paraneoplastic Syndromes; Recurrence; Reed-Sternberg Cells; Sweating; Tumor Necrosis Factor-alpha; Vinblastine | 2010 |
Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; Recurrence; Reed-Sternberg Cells; Tumor Necrosis Factor-alpha; Vinblastine | 2010 |